Influence of physicians' risk perception on switching treatments between high- efficacy and non-high-efficacy disease‑modifying therapies in multiple sclerosis

Seifer, GustavoArun, TarunyaCapela, CarlosLaureys, GuyJones, EddieDominguez-Castro, PatriciaSanchez-de la Rosa, RainelHiltl, SimoneIaffaldano, PietroArun, Tarunya2023-07-282023-07-282023-05-26Mult Scler Relat Disord . 2023 Aug;76:1047702211-035610.1016/j.msard.2023.10477037307690http://hdl.handle.net/20.500.14200/1396The decision of initiating treatment for multiple sclerosis (MS) with a high-efficacy DMT (HE DMT) or non-high-efficacy DMT (non-HE DMT) is influenced by several factors, including risk perception of patients and physicians.enCopyright © 2023. Published by Elsevier B.V.Diseases & disorders of the nervous system (e.g. Parkinson's)NeurologyInfluence of physicians' risk perception on switching treatments between high- efficacy and non-high-efficacy disease‑modifying therapies in multiple sclerosisArticle